JP2004525922A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525922A5
JP2004525922A5 JP2002573034A JP2002573034A JP2004525922A5 JP 2004525922 A5 JP2004525922 A5 JP 2004525922A5 JP 2002573034 A JP2002573034 A JP 2002573034A JP 2002573034 A JP2002573034 A JP 2002573034A JP 2004525922 A5 JP2004525922 A5 JP 2004525922A5
Authority
JP
Japan
Prior art keywords
component
light chain
agent
amino acid
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002573034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525922A (ja
Filing date
Publication date
Priority claimed from US09/810,601 external-priority patent/US6831059B2/en
Application filed filed Critical
Publication of JP2004525922A publication Critical patent/JP2004525922A/ja
Publication of JP2004525922A5 publication Critical patent/JP2004525922A5/ja
Withdrawn legal-status Critical Current

Links

JP2002573034A 2001-03-15 2002-03-11 ゴナドトロピン関連疾患を治療するための組成物および方法 Withdrawn JP2004525922A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/810,601 US6831059B2 (en) 2000-10-20 2001-03-15 Compositions and methods for treating gonadotrophin related illnesses
PCT/US2002/007379 WO2002074327A2 (en) 2001-03-15 2002-03-11 Compositions and methods for treating gonadotrophin related illnesses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010106073A Division JP2010174037A (ja) 2001-03-15 2010-05-06 ゴナドトロピン関連疾患を治療するための組成物および方法

Publications (2)

Publication Number Publication Date
JP2004525922A JP2004525922A (ja) 2004-08-26
JP2004525922A5 true JP2004525922A5 (https=) 2005-12-22

Family

ID=25204201

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002573034A Withdrawn JP2004525922A (ja) 2001-03-15 2002-03-11 ゴナドトロピン関連疾患を治療するための組成物および方法
JP2010106073A Withdrawn JP2010174037A (ja) 2001-03-15 2010-05-06 ゴナドトロピン関連疾患を治療するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010106073A Withdrawn JP2010174037A (ja) 2001-03-15 2010-05-06 ゴナドトロピン関連疾患を治療するための組成物および方法

Country Status (4)

Country Link
US (1) US6831059B2 (https=)
EP (1) EP1368053A4 (https=)
JP (2) JP2004525922A (https=)
WO (1) WO2002074327A2 (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7227010B2 (en) * 1993-09-21 2007-06-05 United States Of America As Represented By The Secretary Of The Army Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
US7192596B2 (en) * 1996-08-23 2007-03-20 The Health Protection Agency Ipsen Limited Recombinant toxin fragments
ATE348178T1 (de) * 1999-08-25 2007-01-15 Allergan Inc Aktivierbare rekombinante neurotoxine
US7838008B2 (en) * 1999-12-07 2010-11-23 Allergan, Inc. Methods for treating diverse cancers
US7838007B2 (en) 1999-12-07 2010-11-23 Allergan, Inc. Methods for treating mammary gland disorders
JP5610659B2 (ja) * 2000-07-21 2014-10-22 ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 多成分生物学的輸送システム
US7273722B2 (en) * 2000-11-29 2007-09-25 Allergan, Inc. Neurotoxins with enhanced target specificity
WO2002061064A2 (de) * 2001-02-01 2002-08-08 Roche Diagnostics Gmbh Verfahren zur herstellung von rekombinantem trypsin
US8071550B2 (en) * 2003-03-03 2011-12-06 Allergan, Inc. Methods for treating uterine disorders
BRPI0508410B8 (pt) 2004-03-03 2021-05-25 Revance Therapeutics Inc composições e métodos para a aplicação tópica e liberação transdérmica de toxinas botulínicas
JP2007527431A (ja) * 2004-03-03 2007-09-27 ルバンス セラピュティックス 局所的診断及び治療用の輸送のための組成物及び方法
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
EP1570855A1 (fr) * 2004-03-04 2005-09-07 Claude Le Louarn Utilisation de toxine botulique pour préparer un médicament destiné à prévenir la pousse de poils
US7811584B2 (en) 2004-06-30 2010-10-12 Allergan, Inc. Multivalent clostridial toxins
US7514088B2 (en) * 2005-03-15 2009-04-07 Allergan, Inc. Multivalent Clostridial toxin derivatives and methods of their use
US7897147B2 (en) * 2004-10-20 2011-03-01 Allergan, Inc. Treatment of premenstrual disorders
WO2006068794A2 (en) * 2004-11-22 2006-06-29 New York University Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof
GB0426397D0 (en) 2004-12-01 2005-01-05 Health Prot Agency Fusion proteins
ZA200707352B (en) 2005-03-03 2009-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
MX2007010674A (es) * 2005-03-03 2007-11-08 Revance Therapeutics Inc Composiciones y metodos para la aplicacion topica y el suministro transdermico de un oligopeptido.
US7419675B2 (en) * 2005-05-26 2008-09-02 Allergan, Inc. Method for treating peritoneal adhesions
ATE518882T1 (de) * 2005-09-19 2011-08-15 Allergan Inc Mit clostridientoxin aktivierbare clostridientoxine
CN103126971A (zh) 2005-11-17 2013-06-05 雷文斯治疗公司 减少非毒素蛋白质的肉毒杆菌毒素组合物和其局部施用及透皮递送方法
US9216228B2 (en) 2007-02-16 2015-12-22 KTB Tumorforschungsgesellschaft MBM Receptor and antigen targeted prodrug
CA2727082C (en) * 2008-06-12 2019-02-26 Syntaxin Limited Fusion proteins for use in suppression of acromegaly
US8796216B2 (en) 2008-06-12 2014-08-05 Syntaxin Limited Suppression of neuroendocrine diseases
EP2161033B1 (en) * 2008-09-09 2013-05-01 Susanne Dr. Grafe Botulinum toxin to introduce temporal infertiliy in a vertebrate (e.g. human)
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
GB0820970D0 (en) * 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
CA2869599C (en) 2012-04-13 2021-07-27 Lubrizol Advanced Materials, Inc. Compounds which inhibit neuronal exocytosis (ii)
EP2649985A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
EP2649984A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
EP2649983A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (II)
US9315549B2 (en) 2013-01-28 2016-04-19 New York University Treatment methods using atoxic neurotoxin derivatives
US11897921B2 (en) 2014-12-09 2024-02-13 New York University Propeptide fusion comprising a mutated clostridium botulinum neurotoxin and a VHH domain
WO2020220085A1 (en) * 2019-05-02 2020-11-05 The University Of Sydney Peptide derivatives and conjugates thereof for treating cancer
US11338016B2 (en) 2020-05-20 2022-05-24 Howard University C-terminal fragment of tetanus toxin (Hc) for treatment of depression
WO2022019583A1 (ko) * 2020-07-23 2022-01-27 (주)메디톡스 엑소좀-매개된 질환 치료제
KR102942184B1 (ko) 2020-07-23 2026-03-20 (주)메디톡스 암 치료제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5186090A (en) 1989-02-23 1990-09-26 Colorado State University Research Foundation Gnrh analogs for destroying gonadotrophs
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US6005086A (en) 1995-01-13 1999-12-21 The Salk Institute For Biological Studies Farnesoid activated receptor polypeptides, and nucleic acid encoding the same
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
GB9617671D0 (en) 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
US5939070A (en) 1996-10-28 1999-08-17 Wisconsin Alumni Research Foundation Hybrid botulinal neurotoxins
GB9721189D0 (en) 1997-10-08 1997-12-03 Speywood Lab The Limited Analgesic conjugates
GB9907429D0 (en) 1999-03-31 1999-05-26 Microbiological Res Authority Modulation of C-fibre activity
US6139845A (en) 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6827931B1 (en) 2000-10-20 2004-12-07 Allergan, Inc. Method for treating endocrine disorders

Similar Documents

Publication Publication Date Title
JP2004525922A5 (https=)
AU2019218786B2 (en) Cell-permeable stapled peptide modules for cellular delivery
CN101815724B (zh) 用于将轭合至其的试剂递送至组织的抑肽酶样多肽
McGonigle Peptide therapeutics for CNS indications
CN103402545B (zh) 疏水性经修饰肽及其在肝特异性靶向中的用途
KR101155294B1 (ko) 면역특이적으로 ＢＬｙＳ에 결합하는 항체
EP2558503A1 (en) Compositions and methods for brain delivery of analgesic peptides
TW201333032A (zh) 使用免疫球蛋白片段之位點專一性ｇｌｐ－２接合物
DE69922261D1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
CN103080125A (zh) 用于治疗性结合物的短且含d氨基酸的多肽及其使用
JP2006506942A5 (https=)
WO2004064787A3 (en) Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
JP7767325B2 (ja) Ｇｌｐ１ｒアゴニスト・ｎｍｄａｒアンタゴニストコンジュゲート
US20230158100A1 (en) Treatment of panx1 associates diseases
CN111093701A (zh) 含有抗globo h抗体的抗体药物偶联物及其用途
MXPA99010523A (es) Metodos para mejorar el funcionamiento del tractogastrointestinal superior.
JP2002525081A5 (https=)
CN102076353A (zh) 胰岛淀粉样多肽和鲑鱼降钙素的衍生杂合肽
JP2026041866A (ja) 構造的に明確なｓｉＲＮＡ－二重可変ドメイン免疫グロブリンコンジュゲート
ATE453667T1 (de) Neovaskular-spezifische peptide
CN118510545A (zh) 用于治疗神经退行性疾病的肽-药物缀合物
JP7239987B2 (ja) 薬物送達のための抗体融合タンパク質
KR20110028433A (ko) 엔케팔린 분해 엑토펩티다제의 강력한 억제제로서의 오피올핀 펩타이드 유도체
WO2023150693A2 (en) Neuregulin-4 analogs and methods of using thereof in disease treatment
WO2003096964A3 (en) Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac